GTC
RYTM icon

Ghost Tree Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History

Ghost Tree Capital’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.13M Sell
78,842
-38,546
-33% -$1.85M 1.25% 30
2024
Q2 		$4.82M Sell
117,388
-7,612
-6% -$304K 1.51% 27
2024
Q1 		$5.42M Buy
+125,000
New +$5.47M 1.5% 22
2022
Q4 		– Sell
-65,000
Closed -$1.59M – 44
2022
Q3 		$1.59M Buy
+65,000
New +$1.21M 0.45% 41
2018
Q1 		– Sell
-25,000
Closed -$727K – 63
2017
Q4 		$727K Buy
+25,000
New +$661K 0.17% 49

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's RYTM Position: Q3 2024 in Review

Ghost Tree Capital reduced its Rhythm Pharmaceuticals (RYTM) stake by 33% in Q3 2024, selling an estimated $1.85M and leaving 78,842 shares worth $4.13M. The position accounts for 1.25% of the portfolio, ranked #30.

Ghost Tree Capital first reported a position in RYTM in Q4 2017 and has held it in 5 quarters since. The position peaked at $5.42M in Q1 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • Ghost Tree Capital held 78,842 shares of Rhythm Pharmaceuticals worth $4.13M as of Q3 2024.
  • Ghost Tree Capital sold 38,546 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $1.85M.
  • Rhythm Pharmaceuticals made up 1.25% of Ghost Tree Capital's portfolio in Q3 2024, its #30 holding.
  • Ghost Tree Capital first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 5 quarters since.
  • Ghost Tree Capital's Rhythm Pharmaceuticals position peaked at $5.42M in Q1 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.